 | • レポートコード：QY2207E09273 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,102,500 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界の薬力（PD）バイオマーカーの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に薬力（PD）バイオマーカーの世界市場のxxx％を占める「曝露バイオマーカー」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「診断」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の薬力（PD）バイオマーカーの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの薬力（PD）バイオマーカー市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの薬力（PD）バイオマーカー市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 薬力（PD）バイオマーカーのグローバル主要メーカーには、Thermo Fisher Scientific、Merck、Bio-Rad Laboratories、QIAGEN、Roche、Danaher Corporation、Siemens Healthcare、Abbott、Agilent Technologiesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 薬力（PD）バイオマーカー市場は、種類と用途によって区分されます。世界の薬力（PD）バイオマーカー市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 曝露バイオマーカー、効果バイオマーカー、感受性バイオマーカー 【用途別セグメント】 診断、創薬、個別化医療、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 薬力（PD）バイオマーカー製品概要 - 種類別市場（曝露バイオマーカー、効果バイオマーカー、感受性バイオマーカー） - 用途別市場（診断、創薬、個別化医療、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の薬力（PD）バイオマーカー販売量予測2017-2028 - 世界の薬力（PD）バイオマーカー売上予測2017-2028 - 薬力（PD）バイオマーカーの地域別販売量 - 薬力（PD）バイオマーカーの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別薬力（PD）バイオマーカー販売量 - 主要メーカー別薬力（PD）バイオマーカー売上 - 主要メーカー別薬力（PD）バイオマーカー価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（曝露バイオマーカー、効果バイオマーカー、感受性バイオマーカー） - 薬力（PD）バイオマーカーの種類別販売量 - 薬力（PD）バイオマーカーの種類別売上 - 薬力（PD）バイオマーカーの種類別価格 ・用途別市場規模（診断、創薬、個別化医療、その他） - 薬力（PD）バイオマーカーの用途別販売量 - 薬力（PD）バイオマーカーの用途別売上 - 薬力（PD）バイオマーカーの用途別価格 ・北米市場 - 北米の薬力（PD）バイオマーカー市場規模（種類別、用途別） - 主要国別の薬力（PD）バイオマーカー市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの薬力（PD）バイオマーカー市場規模（種類別、用途別） - 主要国別の薬力（PD）バイオマーカー市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の薬力（PD）バイオマーカー市場規模（種類別、用途別） - 主要国別の薬力（PD）バイオマーカー市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の薬力（PD）バイオマーカー市場規模（種類別、用途別） - 主要国別の薬力（PD）バイオマーカー市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの薬力（PD）バイオマーカー市場規模（種類別、用途別） - 主要国別の薬力（PD）バイオマーカー市場規模（トルコ、サウジアラビア） ・企業情報 Thermo Fisher Scientific、Merck、Bio-Rad Laboratories、QIAGEN、Roche、Danaher Corporation、Siemens Healthcare、Abbott、Agilent Technologies ・産業チェーン及び販売チャネル分析 - 薬力（PD）バイオマーカーの産業チェーン分析 - 薬力（PD）バイオマーカーの原材料 - 薬力（PD）バイオマーカーの生産プロセス - 薬力（PD）バイオマーカーの販売及びマーケティング - 薬力（PD）バイオマーカーの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 薬力（PD）バイオマーカーの産業動向 - 薬力（PD）バイオマーカーのマーケットドライバー - 薬力（PD）バイオマーカーの課題 - 薬力（PD）バイオマーカーの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Pharmacodynamic (PD) Biomarkers Market
The global Pharmacodynamic (PD) Biomarkers market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Exposure Biomarkers accounting for % of the Pharmacodynamic (PD) Biomarkers global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Diagnostics segment is altered to an % CAGR throughout this forecast period.
China Pharmacodynamic (PD) Biomarkers market size is valued at US$ million in 2021, while the North America and Europe Pharmacodynamic (PD) Biomarkers are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Pharmacodynamic (PD) Biomarkers landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmacodynamic (PD) Biomarkers market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmacodynamic (PD) Biomarkers market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmacodynamic (PD) Biomarkers market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmacodynamic (PD) Biomarkers market.
Global Pharmacodynamic (PD) Biomarkers Scope and Market Size
Pharmacodynamic (PD) Biomarkers market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Pharmacodynamic (PD) Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Exposure Biomarkers
Effect Biomarkers
Susceptibility Biomarkers
Segment by Application
Diagnostics
Drug Discovery
Personalized Medicine
Others
By Company
Thermo Fisher Scientific
Merck
Bio-Rad Laboratories
QIAGEN
Roche
Danaher Corporation
Siemens Healthcare
Abbott
Agilent Technologies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacodynamic (PD) Biomarkers Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Exposure Biomarkers
1.2.3 Effect Biomarkers
1.2.4 Susceptibility Biomarkers
1.3 Market by Application
1.3.1 Global Pharmacodynamic (PD) Biomarkers Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharmacodynamic (PD) Biomarkers Market Perspective (2017-2028)
2.2 Pharmacodynamic (PD) Biomarkers Growth Trends by Region
2.2.1 Pharmacodynamic (PD) Biomarkers Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pharmacodynamic (PD) Biomarkers Historic Market Size by Region (2017-2022)
2.2.3 Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Region (2023-2028)
2.3 Pharmacodynamic (PD) Biomarkers Market Dynamics
2.3.1 Pharmacodynamic (PD) Biomarkers Industry Trends
2.3.2 Pharmacodynamic (PD) Biomarkers Market Drivers
2.3.3 Pharmacodynamic (PD) Biomarkers Market Challenges
2.3.4 Pharmacodynamic (PD) Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacodynamic (PD) Biomarkers Players by Revenue
3.1.1 Global Top Pharmacodynamic (PD) Biomarkers Players by Revenue (2017-2022)
3.1.2 Global Pharmacodynamic (PD) Biomarkers Revenue Market Share by Players (2017-2022)
3.2 Global Pharmacodynamic (PD) Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmacodynamic (PD) Biomarkers Revenue
3.4 Global Pharmacodynamic (PD) Biomarkers Market Concentration Ratio
3.4.1 Global Pharmacodynamic (PD) Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacodynamic (PD) Biomarkers Revenue in 2021
3.5 Pharmacodynamic (PD) Biomarkers Key Players Head office and Area Served
3.6 Key Players Pharmacodynamic (PD) Biomarkers Product Solution and Service
3.7 Date of Enter into Pharmacodynamic (PD) Biomarkers Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacodynamic (PD) Biomarkers Breakdown Data by Type
4.1 Global Pharmacodynamic (PD) Biomarkers Historic Market Size by Type (2017-2022)
4.2 Global Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Type (2023-2028)
5 Pharmacodynamic (PD) Biomarkers Breakdown Data by Application
5.1 Global Pharmacodynamic (PD) Biomarkers Historic Market Size by Application (2017-2022)
5.2 Global Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pharmacodynamic (PD) Biomarkers Market Size (2017-2028)
6.2 North America Pharmacodynamic (PD) Biomarkers Market Size by Type
6.2.1 North America Pharmacodynamic (PD) Biomarkers Market Size by Type (2017-2022)
6.2.2 North America Pharmacodynamic (PD) Biomarkers Market Size by Type (2023-2028)
6.2.3 North America Pharmacodynamic (PD) Biomarkers Market Share by Type (2017-2028)
6.3 North America Pharmacodynamic (PD) Biomarkers Market Size by Application
6.3.1 North America Pharmacodynamic (PD) Biomarkers Market Size by Application (2017-2022)
6.3.2 North America Pharmacodynamic (PD) Biomarkers Market Size by Application (2023-2028)
6.3.3 North America Pharmacodynamic (PD) Biomarkers Market Share by Application (2017-2028)
6.4 North America Pharmacodynamic (PD) Biomarkers Market Size by Country
6.4.1 North America Pharmacodynamic (PD) Biomarkers Market Size by Country (2017-2022)
6.4.2 North America Pharmacodynamic (PD) Biomarkers Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Pharmacodynamic (PD) Biomarkers Market Size (2017-2028)
7.2 Europe Pharmacodynamic (PD) Biomarkers Market Size by Type
7.2.1 Europe Pharmacodynamic (PD) Biomarkers Market Size by Type (2017-2022)
7.2.2 Europe Pharmacodynamic (PD) Biomarkers Market Size by Type (2023-2028)
7.2.3 Europe Pharmacodynamic (PD) Biomarkers Market Share by Type (2017-2028)
7.3 Europe Pharmacodynamic (PD) Biomarkers Market Size by Application
7.3.1 Europe Pharmacodynamic (PD) Biomarkers Market Size by Application (2017-2022)
7.3.2 Europe Pharmacodynamic (PD) Biomarkers Market Size by Application (2023-2028)
7.3.3 Europe Pharmacodynamic (PD) Biomarkers Market Share by Application (2017-2028)
7.4 Europe Pharmacodynamic (PD) Biomarkers Market Size by Country
7.4.1 Europe Pharmacodynamic (PD) Biomarkers Market Size by Country (2017-2022)
7.4.2 Europe Pharmacodynamic (PD) Biomarkers Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size (2017-2028)
8.2 Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size by Type
8.2.1 Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Share by Type (2017-2028)
8.3 Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size by Application
8.3.1 Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Share by Application (2017-2028)
8.4 Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size by Region
8.4.1 Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pharmacodynamic (PD) Biomarkers Market Size (2017-2028)
9.2 Latin America Pharmacodynamic (PD) Biomarkers Market Size by Type
9.2.1 Latin America Pharmacodynamic (PD) Biomarkers Market Size by Type (2017-2022)
9.2.2 Latin America Pharmacodynamic (PD) Biomarkers Market Size by Type (2023-2028)
9.2.3 Latin America Pharmacodynamic (PD) Biomarkers Market Share by Type (2017-2028)
9.3 Latin America Pharmacodynamic (PD) Biomarkers Market Size by Application
9.3.1 Latin America Pharmacodynamic (PD) Biomarkers Market Size by Application (2017-2022)
9.3.2 Latin America Pharmacodynamic (PD) Biomarkers Market Size by Application (2023-2028)
9.3.3 Latin America Pharmacodynamic (PD) Biomarkers Market Share by Application (2017-2028)
9.4 Latin America Pharmacodynamic (PD) Biomarkers Market Size by Country
9.4.1 Latin America Pharmacodynamic (PD) Biomarkers Market Size by Country (2017-2022)
9.4.2 Latin America Pharmacodynamic (PD) Biomarkers Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size (2017-2028)
10.2 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size by Type
10.2.1 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Share by Type (2017-2028)
10.3 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size by Application
10.3.1 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Share by Application (2017-2028)
10.4 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size by Country
10.4.1 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Pharmacodynamic (PD) Biomarkers Introduction
11.1.4 Thermo Fisher Scientific Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Pharmacodynamic (PD) Biomarkers Introduction
11.2.4 Merck Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.2.5 Merck Recent Developments
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Pharmacodynamic (PD) Biomarkers Introduction
11.3.4 Bio-Rad Laboratories Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.3.5 Bio-Rad Laboratories Recent Developments
11.4 QIAGEN
11.4.1 QIAGEN Company Details
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Pharmacodynamic (PD) Biomarkers Introduction
11.4.4 QIAGEN Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.4.5 QIAGEN Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Pharmacodynamic (PD) Biomarkers Introduction
11.5.4 Roche Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.5.5 Roche Recent Developments
11.6 Danaher Corporation
11.6.1 Danaher Corporation Company Details
11.6.2 Danaher Corporation Business Overview
11.6.3 Danaher Corporation Pharmacodynamic (PD) Biomarkers Introduction
11.6.4 Danaher Corporation Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.6.5 Danaher Corporation Recent Developments
11.7 Siemens Healthcare
11.7.1 Siemens Healthcare Company Details
11.7.2 Siemens Healthcare Business Overview
11.7.3 Siemens Healthcare Pharmacodynamic (PD) Biomarkers Introduction
11.7.4 Siemens Healthcare Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.7.5 Siemens Healthcare Recent Developments
11.8 Abbott
11.8.1 Abbott Company Details
11.8.2 Abbott Business Overview
11.8.3 Abbott Pharmacodynamic (PD) Biomarkers Introduction
11.8.4 Abbott Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.8.5 Abbott Recent Developments
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Details
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Pharmacodynamic (PD) Biomarkers Introduction
11.9.4 Agilent Technologies Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.9.5 Agilent Technologies Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global Pharmacodynamic (PD) Biomarkers Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Exposure Biomarkers
Table 3. Key Players of Effect Biomarkers
Table 4. Key Players of Susceptibility Biomarkers
Table 5. Global Pharmacodynamic (PD) Biomarkers Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Pharmacodynamic (PD) Biomarkers Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Pharmacodynamic (PD) Biomarkers Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Pharmacodynamic (PD) Biomarkers Market Share by Region (2017-2022)
Table 9. Global Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Pharmacodynamic (PD) Biomarkers Market Share by Region (2023-2028)
Table 11. Pharmacodynamic (PD) Biomarkers Market Trends
Table 12. Pharmacodynamic (PD) Biomarkers Market Drivers
Table 13. Pharmacodynamic (PD) Biomarkers Market Challenges
Table 14. Pharmacodynamic (PD) Biomarkers Market Restraints
Table 15. Global Pharmacodynamic (PD) Biomarkers Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Pharmacodynamic (PD) Biomarkers Revenue Share by Players (2017-2022)
Table 17. Global Top Pharmacodynamic (PD) Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacodynamic (PD) Biomarkers as of 2021)
Table 18. Ranking of Global Top Pharmacodynamic (PD) Biomarkers Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Pharmacodynamic (PD) Biomarkers Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pharmacodynamic (PD) Biomarkers Product Solution and Service
Table 22. Date of Enter into Pharmacodynamic (PD) Biomarkers Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pharmacodynamic (PD) Biomarkers Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Pharmacodynamic (PD) Biomarkers Revenue Market Share by Type (2017-2022)
Table 26. Global Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Pharmacodynamic (PD) Biomarkers Revenue Market Share by Type (2023-2028)
Table 28. Global Pharmacodynamic (PD) Biomarkers Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Pharmacodynamic (PD) Biomarkers Revenue Share by Application (2017-2022)
Table 30. Global Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Pharmacodynamic (PD) Biomarkers Revenue Share by Application (2023-2028)
Table 32. North America Pharmacodynamic (PD) Biomarkers Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Pharmacodynamic (PD) Biomarkers Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Pharmacodynamic (PD) Biomarkers Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Pharmacodynamic (PD) Biomarkers Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Pharmacodynamic (PD) Biomarkers Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Pharmacodynamic (PD) Biomarkers Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Pharmacodynamic (PD) Biomarkers Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Pharmacodynamic (PD) Biomarkers Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Pharmacodynamic (PD) Biomarkers Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Pharmacodynamic (PD) Biomarkers Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Pharmacodynamic (PD) Biomarkers Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Pharmacodynamic (PD) Biomarkers Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Pharmacodynamic (PD) Biomarkers Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Pharmacodynamic (PD) Biomarkers Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Pharmacodynamic (PD) Biomarkers Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Pharmacodynamic (PD) Biomarkers Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Pharmacodynamic (PD) Biomarkers Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Pharmacodynamic (PD) Biomarkers Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Pharmacodynamic (PD) Biomarkers Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Pharmacodynamic (PD) Biomarkers Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Pharmacodynamic (PD) Biomarkers Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Pharmacodynamic (PD) Biomarkers Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Pharmacodynamic (PD) Biomarkers Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Pharmacodynamic (PD) Biomarkers Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Pharmacodynamic (PD) Biomarkers Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Pharmacodynamic (PD) Biomarkers Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Pharmacodynamic (PD) Biomarkers Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Pharmacodynamic (PD) Biomarkers Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Pharmacodynamic (PD) Biomarkers Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Pharmacodynamic (PD) Biomarkers Market Size by Country (2023-2028) & (US$ Million)
Table 62. Thermo Fisher Scientific Company Details
Table 63. Thermo Fisher Scientific Business Overview
Table 64. Thermo Fisher Scientific Pharmacodynamic (PD) Biomarkers Product
Table 65. Thermo Fisher Scientific Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022) & (US$ Million)
Table 66. Thermo Fisher Scientific Recent Developments
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck Pharmacodynamic (PD) Biomarkers Product
Table 70. Merck Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022) & (US$ Million)
Table 71. Merck Recent Developments
Table 72. Bio-Rad Laboratories Company Details
Table 73. Bio-Rad Laboratories Business Overview
Table 74. Bio-Rad Laboratories Pharmacodynamic (PD) Biomarkers Product
Table 75. Bio-Rad Laboratories Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022) & (US$ Million)
Table 76. Bio-Rad Laboratories Recent Developments
Table 77. QIAGEN Company Details
Table 78. QIAGEN Business Overview
Table 79. QIAGEN Pharmacodynamic (PD) Biomarkers Product
Table 80. QIAGEN Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022) & (US$ Million)
Table 81. QIAGEN Recent Developments
Table 82. Roche Company Details
Table 83. Roche Business Overview
Table 84. Roche Pharmacodynamic (PD) Biomarkers Product
Table 85. Roche Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022) & (US$ Million)
Table 86. Roche Recent Developments
Table 87. Danaher Corporation Company Details
Table 88. Danaher Corporation Business Overview
Table 89. Danaher Corporation Pharmacodynamic (PD) Biomarkers Product
Table 90. Danaher Corporation Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022) & (US$ Million)
Table 91. Danaher Corporation Recent Developments
Table 92. Siemens Healthcare Company Details
Table 93. Siemens Healthcare Business Overview
Table 94. Siemens Healthcare Pharmacodynamic (PD) Biomarkers Product
Table 95. Siemens Healthcare Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022) & (US$ Million)
Table 96. Siemens Healthcare Recent Developments
Table 97. Abbott Company Details
Table 98. Abbott Business Overview
Table 99. Abbott Pharmacodynamic (PD) Biomarkers Product
Table 100. Abbott Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022) & (US$ Million)
Table 101. Abbott Recent Developments
Table 102. Agilent Technologies Company Details
Table 103. Agilent Technologies Business Overview
Table 104. Agilent Technologies Pharmacodynamic (PD) Biomarkers Product
Table 105. Agilent Technologies Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022) & (US$ Million)
Table 106. Agilent Technologies Recent Developments
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmacodynamic (PD) Biomarkers Market Share by Type: 2021 VS 2028
Figure 2. Exposure Biomarkers Features
Figure 3. Effect Biomarkers Features
Figure 4. Susceptibility Biomarkers Features
Figure 5. Global Pharmacodynamic (PD) Biomarkers Market Share by Application: 2021 VS 2028
Figure 6. Diagnostics Case Studies
Figure 7. Drug Discovery Case Studies
Figure 8. Personalized Medicine Case Studies
Figure 9. Others Case Studies
Figure 10. Pharmacodynamic (PD) Biomarkers Report Years Considered
Figure 11. Global Pharmacodynamic (PD) Biomarkers Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Pharmacodynamic (PD) Biomarkers Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Pharmacodynamic (PD) Biomarkers Market Share by Region: 2021 VS 2028
Figure 14. Global Pharmacodynamic (PD) Biomarkers Market Share by Players in 2021
Figure 15. Global Top Pharmacodynamic (PD) Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacodynamic (PD) Biomarkers as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Pharmacodynamic (PD) Biomarkers Revenue in 2021
Figure 17. North America Pharmacodynamic (PD) Biomarkers Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Pharmacodynamic (PD) Biomarkers Market Size Market Share by Type (2017-2028)
Figure 19. North America Pharmacodynamic (PD) Biomarkers Market Size Market Share by Application (2017-2028)
Figure 20. North America Pharmacodynamic (PD) Biomarkers Market Size Share by Country (2017-2028)
Figure 21. United States Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Pharmacodynamic (PD) Biomarkers Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Pharmacodynamic (PD) Biomarkers Market Size Market Share by Type (2017-2028)
Figure 25. Europe Pharmacodynamic (PD) Biomarkers Market Size Market Share by Application (2017-2028)
Figure 26. Europe Pharmacodynamic (PD) Biomarkers Market Size Share by Country (2017-2028)
Figure 27. Germany Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Pharmacodynamic (PD) Biomarkers Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Pharmacodynamic (PD) Biomarkers Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Pharmacodynamic (PD) Biomarkers Market Size Share by Region (2017-2028)
Figure 37. China Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Pharmacodynamic (PD) Biomarkers Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Pharmacodynamic (PD) Biomarkers Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Pharmacodynamic (PD) Biomarkers Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Pharmacodynamic (PD) Biomarkers Market Size Share by Country (2017-2028)
Figure 47. Mexico Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Pharmacodynamic (PD) Biomarkers Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Pharmacodynamic (PD) Biomarkers Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Pharmacodynamic (PD) Biomarkers Market Size Share by Country (2017-2028)
Figure 53. Turkey Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
Figure 57. Merck Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
Figure 58. Bio-Rad Laboratories Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
Figure 59. QIAGEN Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
Figure 60. Roche Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
Figure 61. Danaher Corporation Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
Figure 62. Siemens Healthcare Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
Figure 63. Abbott Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
Figure 64. Agilent Technologies Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
乳がんバイオマーカーのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Breast Cancer Biomarkers Market Due to the COVID-19 pandemic, the global Breast Cancer Biomarkers market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022…- 世界のPARP阻害剤バイオマーカー試験製品市場予測（～2028年）：検査キット、検査アッセイ The PARP Inhibitor Biomarkers Testing Product market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 世界の血清バイオマーカー市場予測（～2028年）：肝細胞癌血清バイオマーカー、肺癌血清バイオマーカー、膵臓＆胆道癌血清バイオマーカー、乳癌血清バイオマーカー、神経膠芽腫血清バイオマーカー、その他 The Serum Biomarkers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
- 世界の血清がんバイオマーカー市場予測（～2028年）：肝細胞癌血清バイオマーカー、肺癌血清バイオマーカー、膵臓＆胆道癌血清バイオマーカー、乳癌血清バイオマーカー、神経膠芽腫血清バイオマーカー、その他 The Serum Cancer Biomarkers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- ニューロンマーカーのグローバル市場インサイト・予測（～2028年） A major percentage of world population is affected by neurological disorders, this in turn is causing major disabilities globally. Due to the high incidence of neurological disorders, there is the need for biomarkers as biomarkers measure biological states and are used for indication of both pathoge…